JP2021527699A5 - - Google Patents

Info

Publication number
JP2021527699A5
JP2021527699A5 JP2020571366A JP2020571366A JP2021527699A5 JP 2021527699 A5 JP2021527699 A5 JP 2021527699A5 JP 2020571366 A JP2020571366 A JP 2020571366A JP 2020571366 A JP2020571366 A JP 2020571366A JP 2021527699 A5 JP2021527699 A5 JP 2021527699A5
Authority
JP
Japan
Prior art keywords
composition according
gram
positive bacteria
lactam antibiotic
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020571366A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021527699A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/038525 external-priority patent/WO2019246552A1/en
Publication of JP2021527699A publication Critical patent/JP2021527699A/ja
Publication of JP2021527699A5 publication Critical patent/JP2021527699A5/ja
Pending legal-status Critical Current

Links

JP2020571366A 2018-06-22 2019-06-21 溶解素及びその誘導体がスタフィロコッカス・アウレウス及びグラム陽性細菌を抗生物質に再感作する Pending JP2021527699A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862688756P 2018-06-22 2018-06-22
US62/688,756 2018-06-22
PCT/US2019/038525 WO2019246552A1 (en) 2018-06-22 2019-06-21 Lysins and derivatives thereof resensitize staphylococcus aureus and gram-positive bacteria to antibiotics

Publications (2)

Publication Number Publication Date
JP2021527699A JP2021527699A (ja) 2021-10-14
JP2021527699A5 true JP2021527699A5 (https=) 2022-06-29

Family

ID=68983065

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020571366A Pending JP2021527699A (ja) 2018-06-22 2019-06-21 溶解素及びその誘導体がスタフィロコッカス・アウレウス及びグラム陽性細菌を抗生物質に再感作する

Country Status (11)

Country Link
US (1) US20210260070A1 (https=)
EP (1) EP3809851A4 (https=)
JP (1) JP2021527699A (https=)
KR (1) KR20210024005A (https=)
CN (2) CN112867398A (https=)
AU (1) AU2019288723A1 (https=)
BR (1) BR112020026267A2 (https=)
CA (1) CA3104650A1 (https=)
IL (1) IL279596A (https=)
MX (1) MX2020013935A (https=)
WO (1) WO2019246552A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3980049A4 (en) * 2019-04-11 2023-07-19 Contrafect Corporation METHOD OF TREATMENT AND PREVENTION OF BONE AND JOINT INFECTIONS
US20220087266A1 (en) * 2020-09-22 2022-03-24 Mars, Incorporated Compositions and methods for controlling mycotoxin production
WO2022261360A1 (en) * 2021-06-09 2022-12-15 Contrafect Corporation Plyss2 lysins and variants thereof for use against multidrug resistant gram-positive bacteria
JP2024523382A (ja) * 2021-06-15 2024-06-28 フェリング・ベー・フェー バンコマイシン耐性腸球菌に対するバクテリオファージ
CN120513297A (zh) * 2023-01-09 2025-08-19 华中农业大学 细菌裂解酶及其应用
CN117051043B (zh) * 2023-10-11 2024-01-30 圆因(北京)生物科技有限公司 一种基于环状rna编码耐甲氧西林金黄色葡萄球菌内溶素及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2103308A1 (de) * 2008-03-20 2009-09-23 PhytoLine GmbH Verfahren zur Herstellung eines Gemisches von Bakteriophagen und deren Verwendung für die Therapie von Antibiotika-resistenten Staphylococcen
EP3263588A1 (en) * 2008-07-03 2018-01-03 The Rockefeller University Isolated staphylococcus-specific soluble binding molecule
TW201028154A (en) * 2008-10-23 2010-08-01 Novozymes As Antibiotic synergism
KR20210121313A (ko) * 2012-05-09 2021-10-07 콘트라펙트 코포레이션 그람 양성 박테리아에 대한 박테리오파지 리신과 항생제의 병용물
AU2016324307B2 (en) * 2015-09-17 2021-10-21 Contrafect Corporation Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby

Similar Documents

Publication Publication Date Title
JP2021527699A5 (https=)
ter Boo et al. Antimicrobial delivery systems for local infection prophylaxis in orthopedic-and trauma surgery
Trampuz et al. Antimicrobial agents in orthopaedic surgery: prophylaxis and treatment
US10017542B2 (en) Antimicrobial peptides and methods of use thereof
RU2363489C2 (ru) Способ применения антибиотиков
ES2436614T3 (es) Composiciones y procedimientos de tratamiento de bacterias
WO2017049242A2 (en) Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
RU2017102306A (ru) Лизины ацинетобактеров
HUP0002662A2 (hu) Lizosztafint magában vagy antibiotikus kombinációban tartalmazó gyógyászati készítmény, amely stafilokokkusz fertőzések kezelésére alkalmazható
SK91498A3 (en) Nisin in combination with glycerol monolaurate active against helicobacter
JP2017526627A5 (https=)
JP2012501349A5 (https=)
IL275795B2 (en) Medical bacteriophage preparations for the treatment of staphylococcal infection
JP6204930B2 (ja) 多価ワクチンによる黄色ブドウ球菌感染症からの保護
JP2021527699A (ja) 溶解素及びその誘導体がスタフィロコッカス・アウレウス及びグラム陽性細菌を抗生物質に再感作する
UA129222C2 (uk) Лікарський засіб і його застосування для лікування бактеріальних інфекцій, пов'язаних з біоплівкою
US20110034557A1 (en) Antimicrobial compositions and uses thereof
Kruglikova et al. Surgical maggots and the history of their medical use
RU2020142378A (ru) Ресенсибилизация staphylococcus aureus и грамположительных бактерий к антибиотикам лизинами и их производными
Sedarat et al. A Consideration of antibacterial agent efficacies in the treatment and prevention of formation of Staphylococcus aureus biofilm
JP2022525914A5 (https=)
JP2022526624A5 (https=)
JP2023513934A5 (https=)
De Gaudio et al. What is the role of streptogramins in intensive care?
RU2021129174A (ru) Способ лечения и предотвращения инфекций костей и суставов